Prof. Richard J. Ablin

Department of Pathology

University of Arizona College of Medicine, USA

Research Professor

Email: [email protected]

Qualifications

1967  Ph.D., Major Microbiology, Minor Immunology, State University of New York at Buffalo, USA

1962 A.B., Major Biology, Minor Chemistry, Lake Forest College, USA

Publications (Selected)

1. Ablin, R.J. Recensione: Il grande inganno sulla prostata, di Richard Ablin. 2017.

2. Ablin, R.J., Owen, S. and Jiang, W.G. Prostate Transglutaminase (TGase-4) Induces Epithelial– to-Mesenchymal Transition in Prostate Cancer Cells. 2017.
3. Haines, I., Ablin, R.J. and Miklos, G. Authors’ reply to Kole. 2016.
4. Haines, I., Ablin, R.J. and Miklos, G. Screening for prostate cancer: Time to put all the data on the table. 2016.
5. Kaur, K., Fayad, R., Saxena, A. and Bennett, C.L. Fluoroquinolone-related neuropsychiatric and mitochondrial toxicity: A collaborative investigation by scientists and members of a social network. 2016.
6. Owen, S., Dart, A., Cui, Y. and Jiang, W.G. Potential interactions between Interleukin-20 and Transglutaminase 4 might affect prostate cancer cell function. 2015.
7. Owen, S., Martin, T.A., Dart, A. and Jiang, W.G. The prostate Transglutaminase, TGase-4, is potentially linked to the junctional proteins at tight junctions of prostate tissues and prostate cancer cells. 2015.
8. Haines, I., Ablin, R.J. and Miklos, G. Prostate cancer screening in Europe. 2015.
9. Hermanson, T., Sartor, O., Ablin, R.J. and Bennett, C.L. Editorial Comment. 2015.
10. Qureshi, Z., Bennett, C.L., Hermanson, T. and Ablin, R.J. The Ethical Dilemma Surrounding Prostate Specific Antigen (PSA) Screening. 2015.
11. Bennett, C.L., Chen, B.K., Hermanson, T. and Armitage, J.O. Regulatory and clinical considerations for biosimilar oncology drugs. 2014.
12. Hermanson, T., Sartor, O., Ablin, R.J. and Bennett, C.L. Editorial comment. 2014.
13. Ablin, R.J. Prostate 'hoax' book contains no conspiracy theories. 2014.
14. Lu, K., Kessler, S.J.B.A., Schulz, R. and Bennett, C.L. Systematic Approach to Pharmacovigilance beyond the Limits: The Southern Network on Adverse Reactions (SONAR) Projects. 2014.
15. O'Callaghan, T. and Ablin, R.J. More harm than good. 2014.
16. Lugnani, F., Simone, G., Biava, P.M. and Ablin, R.J. The Role of Neuroendocrine Cells in Prostate Cancer: A Comprehensive Review of Current Literature and Subsequent Rationale to Broaden and Integrate Current Treatment Modalities. 2013.
17. Jiang, W.G., Ye, L., Sanders, A.J. and Mason, M.D. Prostate transglutaminase (TGase-4, TGaseP) enhances the adhesion of prostate cancer cells to extracellular matrix, the potential role of TGase-core domain. 2013.
18. Bennett, C.L., Jacob, S., Dunn, B. and Fujimura, Y. Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: A report from the Southern Network on Adverse Reactions (SONAR). 2013.
19. Lu, Z., Qureshi, Z.P., Chen, B.K. and Bennett, C.L. Why Is Cancer Care So Expensive: Potential Implications of Fraud and Abuse. 2012.
20. Eichel, E.W. and Ablin, R.J. The Female Prostate: Correcting the G-Spot. 2012.
21. Harris, D., Hilgaertner, J., Simonson, C. and Badowski, M. Cell-based therapy for epithelial wounds. 2012.
22. Ablin, R.J. The United States Preventive Services Task Force Recommendation against Prostate-Specific Antigen Screening—Point. 2012.
23. Brett, A. and Ablin, R.J. Prostate-Cancer Screening - What the US Preventive Services Task Force Left Out. 2011.

Personal Details

https://www.researchgate.net/profile/Richard-Ablin

WoS Researcher ID: CAJ-6382-2022